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Inflammatory lung diseases cause a significant amount of morbidity and mortality. However, the
mechanisms that control the initiation and resolution of pulmonary inflammatory responses have
not been well-elucidated. Histopathological data suggests that the lung responds with a similar
pattern of inflammation to diverse range of injurious stimuli.

In order to investigate the

immunopathogenesis of lung inflammation, a series of in vivo models of lung inflammation were
generated in CBAlJ and CD-I mice by respiratory reovirus IlL infection. Using this approach, it
was observed in CBAlJ mice that a relatively low titer of reovirus IlL induced a pattern of
intraluminal fibrosis in the bronchoalveolar compartment of the lung that is characteristic of the
disorder bronchiolitis obliterans organizing pneumonia (BOOP). When higher titers of reovirus
IlL were used to inoculate CBA/J mice, most animals developed acute respiratory distress
syndrome CARDS), which is characterized by widespread vascular endothelial and respiratory
epithelial cell damage. Conversely, the pulmonary response of CD~ 1 mice to respiratory reovirus
IlL was not acute or fibrotic, but instead was characterized by a bronchiocentric, lymphocytic
cellular infiltrate that recapitulates the disorder follicular bronchiolitis (FB).

FB was also

described as a simultaneous component of the inflammatory response in CBA/J mice in addition
to BOOP and ARDS. Collectively the models of reovirus IlL-induced FB, BOOP, and ARDS
represent a spectrum of inflammatory lung disorders that are generated by one agent, thus
allowing the exploration of cellular and molecular mechanisms that regulate the pulmonary
inflammatory response.
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CHAPTER ONE

General Introduction and Review of the Literature
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General Introduction

The cellular and molecular interactions among pulmonary inflammatory and resident
parenchymal cells following injury or infection of the lung are incompletely understood
(Colby 1997). Histopathological observations of lung inflammation (including fibrosis)
indicate that the lung responds with a similar pattern of inflammation to wide range of
inflammatory stimuli as diverse as connective tissue disorders, lung transplantation, bone
transplantation, exposure to toxic agents, and pathogenic infections (Epler 1992; Wright, et
al. 1992; Wells and du Bois 1993; Myers and Colby 1993; Kanda, et al. 1997).

The

following investigations of the immunopathogenesis of lung inflammation are focused on
three models of human lung disorders that primarily affect the distal airways, which include
the small airways and air spaces of the lung.

These surfaces collectively compose the

largest interface that the body maintains with the outside environment (Pabst 1995).
However, very little is known about the interactions of the respiratory epithelium with
infiltrating inflammatory cells following injury or infection of the distal regions of the lung.
Respiratory reovirus IlL infection of selected mouse strains has been used to recapitulate
Follicular Bronchiolitis (FB), Bronchiolitis Obliterans Organizing Pneumonia (BOOP), and
Acute Respiratory Distress Syndrome (ARDS).

FB, the first -of these models to be

described, is a lymphoid-proliferative disorder that primarily affects the small conducting
airways of the lung, but does not usually result in alterations to the architecture of the lung
(Yousem 1985; Kinane 1993). The second model is of BOOP, which is characterized by
the presence of intraluminal fibrotic lesions in the small airways of the lung and in the
alveolar spaces (Epler 1985).

BOOP is also typically associated with a lympoid-

proliferative component like that observed with FB (Epler 1995).

Lastly, respiratory

reovirus IlL infection is also used to generate a model of ARDS, a severe inflammatory
disease of the lung characterized by widespread, massive alveolar epithelial and vascular
endothelial cell damage (Luce 1998).
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FB, BOOP, and ARDS are disorders that primarily affect the distal regions of the
lung, which include small airways (bronchioles) and air spaces (alveoli) as well as the
intervening interstitial and vascular tissue.

Bronchiolar lumens are characterized by a

mucosal epithelial lining and then moving from the lumen towards the adventitia, a basement
membrane, a thin layer lamina propria, an elastic tissue membrane, a layer of smooth muscle,
and an adventitial connective tissue layer that is associated with the surrounding alveolar and
perivascular interstitium (Colby 1998). The bronchioles lead into the alveolar ducts, which
communicate directly with the alveolar air spaces (Wang 1988).

In humans, as the

bronchioles transition into alveolar ducts a number of air spaces may be found along the
walls of the bronchioles (Wang 1988). These bronchioles are referred to as respiratory
bronchioles; however, respiratory bronchioles are not typically found in rodents (Pabst
1992). A schematic representing the cellular and anatomic features of FB, BOOP, and
ARDS is shown in Figure 1.1.
The lung alveolar epithelium covers a large surface area (Simon and Paine 1995).
Two types of cells comprise the alveolar epithelium, Type I cells and Type II cells (Crapo
1982). Type I cells are characterized by an extremely attenuated cytoplasm that is spread
over a relatively large area (Simon and Paine 1995). Approximately 93% of the alveolar
epithelium surface area is composed of Type I cells (Simon and Paine 1995). A basement
membrane underlies the alveolar epithelium and allows capillary endothelial cells to be
juxtaposed to Type I cells (Crapo 1982). The other 7% of the alveolar surface is covered by
Type II cells (Saffiotti 1996). Contrary to the thin, attenuated morphology of Type I cells,
Type II cells are compact and cuboidal (Simon and Paine 1995). Each Type II cell covers
only 3% of the basal lamina surface area as does each Type I cell, but Type II cells are
progenitor cells for Type I cells and can differentiate into Type I cells in order to replace
damaged epithelium (Simon and Paine 1995). However, Type I cells represent a tenninally
differentiated cell type and are not able to revert to a Type II state (Simon and Paine 1995).
While Type I cells primary function is to mediate the exchange of gases between the
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Figure 1.1: Schematic of FB, BOOP, and ARDS. Br = bronchiole, PA = pulmonary
artery
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alveolar lumen and the vasculature, Type II cells are more involved in the synthesis and
recycling of factors that maintain normal lung physiology (Rooney 1994).

The

progression of lung inflammation to fibrosis appears to involve intimate cell-to-cell contact
between the alveolar epithelium and fibroblasts in the lung interstitium (Rhodes, et ale 1989;
Adamson, et al. 1988). The failure of type II cells to differentiate quickly enough to
alveolar type I cells (type I) in order to replace damaged respiratory epithelium has been
proposed as an important event leading to intra-alveolar fibrosis (Rhodes, et al. 1989;
Adamson, et al. 1988). In addition, a rat model of silicosis-induced interstitial lung fibrosis
showed that type II produce Transforming Growth Factor (TGFJ3)-I, a potent stimulator of
fibroblasts to secrete collagen and precedes extra cellular matrix (ECM) proteins (Williams,
et ale 1993).

There have also been investigations performed demonstrating that lung

fibroblasts do not just passively respond to inflammatory and fibrogenic signals, but that
they can also regulate their own proliferation via the secretion of Platelet-Derived Growth
Factor (PDGF)A , Fibroblast Growth Factor (FGF)-2, and Insulin Growth Factor (IGF)-1
(Rapolee and Werb 1992; Story, et al. 1993; Shoji, et ale 1990).
Investigations into the mechanisms that control inflammation In the lung have
traditionally focused on professional inflammatory cells (macrophages, lymphocytes,
eosinophils, and neutrophils) which gather in the alveolar spaces following lung injury or
pathogenic infection (Simon and Paine 1995). In general, organized lymphoid tissue is
usually absent in normal adult human or murine lungs (Colby 1998).

However, under

conditions of chronic inflammation lymphoid follicles characteristic of FB may develop
along bronchioles as a component of the mucosal immune response (Yousem 1991). Lung
parenchymal cells, particularly epithelial cells and fibroblasts, have become increasingly
recognized for their role in the regulation of the inflammatory response under pathologic
conditions (Simon and Paine 1995). Type II cells have been shown to be capable of
processing and presenting antigen to T lymphocytes (Schneeberger 1986). The role of type
II cells as antigen presenting cells is further demonstrated by the fact that isolated type II
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cells can stimulate allogeneic T lymphocytes to proliferate in a mixed lymphocyte reaction
(Annstrong 1992).
Type IT cells are also able to participate in the regulation of inflammatory reactions
by secreting inflammatory cytokines such as, Tumor Necrosis Factor (TNF)a and
Granulocyte Monocyte-Colony Stimulating Factor (GM-CSF) (Piguet, et ale 1993; Nash, et
ale 1993; Tazi, et ale 1993). Messenger RNA transcripts for Macrophage Inflammatory
Factor (MIP)-2, a potent chemoattractant of neutrophils and lymphocytes has also been
detected in the cytoplasm of type II cells shortly after exposure of the lung epithelium to aquartz in rats (Driscoll, et al. 1996). In general peptide mediators belonging to the cytokine
and growth factor families are being increasingly recognized as important regulators of
inflammation and fibrosis in the lung (Jordana, et ale 1993; Kumar and Lykke 1995). It is
through an elaborate, organized cytokine network that all the cell types involved In a
pulmonary inflammatory response are able to communicate (Jordana, et ale 93; Kumar and
Lykke 95).

Although many investigations into pulmonary cytokine production have

demonstrated alveolar macrophages to be the primary source of cytokines in the lung, more
recent studies suggest that fibroblasts, alveolar epithelial, endothelial, neutrophils,
eosinophils, and lymphocytes are also important sources of cytokines (Kita, et al. 1991;
Zhang, et ale 1995). Early inflammatory events occurring within hours after injury to the
lung epithelium have been associated with the expression of Interleukin (IL-l)a and

IL-l~,

IL-8, Monocyte Chemotactic Protein (MCP), and TNFa. (Jordana, et al. 1993; Zhang, et ale
1995).

Upregulation of TNFa has been reported within hours after lung injury in

experimental models of pulmonary fibrosis generated by exposure of the lung to the toxic
chemotherapeutic agent bleomycin or to silica dust (Piguet, et al. 1990). TNFa has also
been strongly associated with the transformation of a pulmonary inflammatory response
into a fibrotic reaction (Piguet, et al. 1990; Jordana, et al. 1993; Zhang, et al. 1995).
However, fibrosis cannot be initiated solely by the administration of recombinant TNFa
suggesting that multiple factors are required in vivo for inflammatory and fibrotic processes
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to proceed (Piguet, et ale 1990). Clinical studies of human lung inflammation as well as the
bleomycin model of lung injury have also been used to show' that TGF(3 ECM deposition
(Zhang, et al. 1995).
Initial experiments to define the pulmonary cytokine network focused on the release
of cytokines into the cell free bronchoalveolar lavage (BAL) fluid of mice that were
inoculated intratrachearly with influenza virus (Holt, et ale 1986; Hou, et al. 1992). These
experiments demonstrated an early increase in a number of cytokines including IL-l u, IL1(3, TNFu, Interferon (IFN)y and GM-CSF but did not find an increase in the T cell
cytokines, IL-2, IL-3 and IL-4 (Holt, et al. 1986; Hou, et al. 1992). An evaluation of the
cytokine mRNA expression by in situ hybridization analysis of cells obtained from both
lung associated lymph nodes (LALN) and lungs following primary influenza virus infection
demonstrated that the pulmonary T-lymphocyte response to influenza is detected first in the
lymph nodes and then later in the lungs following the emigration of effector T cells from the
LALN to the lungs (Becker, et al. 1991). CD8+ T cells were shown to express mRNA for
IFNy and TNF(3, whereas mRNA for IL-4 and IL-I0 was more prevalent in CD4+ cells
(Becker, et al. 1991). In addition, y/5 T cells predominately expressed IL-2, IL-4, and IFNy (Becker, et al. 1991; Hou, et ale 1995). The frequency of cytokine-secreting cells from the
BAL cells of influenza virus infected mice demonstrated numerous IL-2, IL-4 and IFNy
secreting cells with fewer TNF or IL-I0 secreting cells (!konen, et al. 1994). Depletion of
CD4+ and CD8+ cells significantly decreased the frequency of IL-2 and IL-4 secreting cells
(Ikonen, et al. 1994). In contrast, cells obtained from the lung associated lymph nodes did
not produce IL-4, IL-5 or TNF while IL-2, IL-I0 and INFy expression were prominent
(Jackson, et al. 1987).
Respiratory Syncytial Virus (RSV) infection of the lung has also been used to study
immune responses at respiratory surfaces. It was shown in vitro that RSV initially causes
an abortive infection of alveolar macrophages and the production of TNFu, IL-6, and IL-8,
all of which may modulate the inflammatory responses to the virus (Joel and Chanana
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1985).

Additionally, RSV induced TNFa and IL-l, but not IL-6 and IL-8 mRNA

expression from bronchial epithelial cells, suggesting that cytokines produced by RSVinfected alveolar macrophages may be important in modulating the inflammatory response
to RSV than directly interfering with viral infection or replication (Joel and Chanana 1985).
With RSV immunization, it was shown that the pattern of cytokine expression observed
after i.n. application was dependent on the form of RSV used (Jones and Ada 1987; Jung, et
al. 1993). The most predominant cytokine found in the lungs after foonaHn inactivated

(FI)-RSV inoculation was IL-4 (Jones and Ada 1987; Jung, et af. 1993).

However,

intranasal immunization with viable RSV predominately induced a THI like pattern (Jones
and Ada 1987). The effect of cytokine depletion was evaluated upon restimulation with
either FI-RSV or infection with RSV (Jung, et al. 1993). Simultaneous depletion of both
IL-4 and IL-I0 completely abrogated the pulmonary histopathology in FI-RSV-immunized
mice, while depletion of a-2 or IFNy had no effect suggesting that FI-RSV inoculation
primes for the TH2 cytokines (IL-4, IL-I0) (Jung, et al 1993). In addition, treatment of
mice with IL-4 at the time of immunization with FI-RSV reduced clinical illness after a live
viral challenge that was associated with an augmented CTL response (Kaltreider, et al.
1987). Taken together, these results suggest that different subpopulations of lymphocytes
can be activated by different forms of RSV and the subpopulation-of lymphocytes that are
activated can be selectively modulated by anti-cytokine treatment prior to re-stimulation
(Kaltreider, et al. 1987; Jung, et al. 1993). These experiments collectively demonstrate the
complexity of the inflammatory response of respiratory cell populations, which have been
represented in Figure 1.3.
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Figure 1.2: Schematic of general intra-alveolar inflammatory events.
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within 15 minutes after adsorption (Silverstein and Dales 1968).

Then the reovlrus-

containing endosomes fuse with lysosomes within an hour (Silverstein and Dales 1968).
Proteolysis of the outer capsid then takes about 2 to 3 hours (Silverstein and Dales 1968).
Once the virus particles are uncoated, transcription and replication of new progeny genomes
for all 10 genes and translation of new viral proteins can occur by 10 hours post infection
(Zweerink and Joklik 1970). By that timepoint most of the protein production in the host
cell is for viral proteins (Zweerink and Joklik 70). An alternative pathway may also exist for
reovirus adsorption and penetration that allows reovirus to bypass receptor mediated
endocytosis and lysosome proteolysis (Borsa, et al. 1982; Nibert, et al. 1996). This occurs
when proteolytic lysis outside of the cell causes the partial uncoating of the viral particle,
fonning what is referred to as an intennediate subviral particle (ISVP) (Borsa, et al. 1982;
Nibert, et al. 1996). The ISVPs have then shown to be able to directly enter the host cell
and initiate transcription without interacting with lysosomes (Borsa, et al. 1982, Nibert, et al.
1996). Following the translation of viral proteins and the transcription and replication of
new progeny genome segments, assembly of new virus particles occurs by a mechanism
that is still not clear, but it only results in approximately 1 infectious reovirus particle out of
a 100 assembled virions (Nibert, et al. 1996). Normally, the new reovirus particles are
released from the host cell lytically; however, depending on the· cell type reovirus may
persistently infect the host cell (Ahmed and Fields 1982; Taber, et al. 1976).
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CHAPTER 2

Materials and Methods
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Animals and housing

The following mice were used for investigations relating to this thesis: Sixteen to
eighteen gram female outbred CD-l mice (Charles Rivers Laboratories, Wilmington, MA);
4 to 5 week old female Balb/C (H-2d), C3H (H-2k), and CBAlJ (H-2k) mice (Jackson
Laboratories, Bar Harbor, rvrn); and 4 to 5 week old CBAlJ that were neonatally
thymectomized 4 days after birth (surgery performed by Jackson Laboratories, Bar Harbor,
IvIE).

All mice were maintained in micro-isolator cages under specific pathogen-free

conditions in a BL-2 facility. Cages were housed in a HEPA-filtered animal isolator clean
room (Nuaire Inc, Plymouth, MN).

Inoculation protocol
Animals were anesthetized with an intraperitoneal (Lp.) injection of 0.15 cc (CBAlJ
mice were inoculated with 0.1 cc because they appeared to be more sensitive to the
anesthetic) of 20% Ketamine and 2% PromAce (Vetalar 100mglml and Acepromazine
Maleate 10mglml respectively; Ayerst Laboratories, New York, NY). CD-I, Balb/C, and
C3H strains of mice were then inoculated intranasally (i.n.) with 1 x 107 PFU of reovirus
IlL in 30 J..lI (15 J..lI in each nostril) of sterile injectable grade 0.9% NaCI (Baxter Healthcare
Corp., Deerfield, IL). Control animals received only the saline solution or the inactivated
reovirus IlL by the identical inoculation procedure. CBAlJ and neonatally thymectomized
CBAlJ mice were inoculated intranasally (i.n.) with reovirus IlL (1 x 106 PFU or 1 x 107

PFU as indicated in the figure legends) in 30 J..lI of 0.9% NaCI (15 J..lI in each nostril)
(Baxter Healthcare Corp., Deerfield, IL). Reovirus IlL at 3.3 x 108 PFU/ml 0.9% NaCI in a
P-60 petri dish was inactivated by exposure to an ultraviolet (UV) light source (30W/G30;
Philips Electronics, Holland) placed 15 cm away for 15 minutes. Control animals received
either 1 x 106 PFU of UV-inactivated virus or only the saline solution by the identical
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inoculation procedure. Reovirus IlL-inoculated mice of all strains were kept physically
isolated from all other experimental and control mice.

Virus

Reovirus IlL was originally obtained from Dr. W. Joklik (Duke University School of
Medicine, Durham, NC).

Third-passage gradient-purified stocks were obtained by

recloning and amplifying parental stocks with a L-929 fibroblast cell line as previously
described (Rubin, et al. 1985). Following the purification of new stocks, infectious viral
titers were obtained by limiting dilution on L-929 monolayers.

Histology

Hematoxylin and Eosin staining was performed on 4 micron sections of lungs fixed
overnight in 10% neutral buffered formalin and embedded in paraffin. Tissue sections were
prepared and stained by the Department of Pathology and Laboratory Medicine, Medical
University of South Carolina.

Electron Microscopy

Cross sectional areas of lung lobes were examined for areas of pathologic change using a
dissecting microscope. 1 nun3 blocks were cut and processed by standard techniques using
2% aqueous osmic acid followed by dehydration through graded alcohols and propylene
oxide. 0.5 J.1m sections were obtained from Epoxy embedded blocks and were placed on
glass slides and stained with Toluidine blue

The sections were examined by light

microscopy and appropriate areas were sectioned at 800 Angstroms, placed on copper grids,
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and stained with uranyl acetate-lead citrate contrast stains. The grids were examined with an
Hitachi H-7000 transmission electron microscope.

Antibodies

The following monoclonal antibodies were used in this study: RA3-6B2, anti-B220;
MI/70.15, anti CDllb (Mac-I); YTS 169.4, anti-CD8a; XMG1.2, anti IFNy; BVD-24G2,

anti IL-4 (Caltag, So. San Francisco, CA); HI29.19, anti-CD4 (Gibco, Gaithersburg, MD);
and reovirus specific rabbit serum (a gift from Dr. Donald Rubin; Vanderbilt University,
Nashville, TN);

Immunohistochemistry

Animals were sacrificed with an i.p. injection of 0.2 cc Sodium Nembutal (50
mglml; Abbott Laboratories, No. Chicago, IL). The lungs were inflated in situ with OCT
compound (TissueTek II, Miles Laboratories Inc., Naperville, IL) by tracheal intubation,
removed, suspended in additional OCT compound, and snap-frozen in liquid nitrogen. The
tissues were stored at -70o C. Five micron sequential sections were collected on poly-Llysine (Sigma, St. Louis, MO) treated slides and immediately fixed for 10 minutes in 95%
ethanol at room temperature. After two five-minute washes in PBS, the sections were
blocked for 20 minutes with a solution of 2% normal serum blocking solution (serum from
the species the secondary Ab was made) (Vector Laboratories, Burlingame, CA) and 0.5%
nonfat dried milk in PBS. A 1:50 dilution (in blocking solution) of the primary antibody
was added and incubated for 45 minutes, except for XMG 1.2, anti IFNy, and BVD-24G2,
anti IL-4, which- were incubated overnight at 40 C. After two five-minute PBS washes, the
biotinylated secondary Ab (anti-IgG of the species in which the primary Ab was made)
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(VectorLaboratories,Burlingame,CA)diluted 1:100 in blocking solution was added to the
slides and incubated for 30 minutes. After two additional five-minute PBS washes, the
tissues were treated for 30 minutes with a 1% solution of hydrogen peroxide (Sigma, St.
Louis, MO) in methanol to quench endogenous peroxidase activity.

Following two

additional five-minute washes the slides were incubated for 30 minutes with the solution
containing the avidin-biotin-peroxidase complex

(ABC

kit;

Vector Laboratories,

Burlingame, CA) which was prepared and used according to manufacturer's instructions.
Diaminobenzidine (Sigmafast DAB tablets; Sigma, St. Louis, MO) was prepared according
to the manufacturer's instructions and allowed to react with the peroxidase-labeled tissue for
20 minutes. After two, one minute rinses in distilled water, the tissue was hematoxylin
counter stained (Gill's #1; Baxter, McGaw Park, IL), cleared and dehydrated by successive
gradations through 70%, 95%, and 100% ethanol followed by a final passage in xylene.
The slides were mounted with Accu Mount 60 (Stephens Scientific; Riverdale, NJ).

Titration of infectious virions

Freshly harvested lungs without the associated lymph nodes were removed and
freeze-thawed three times in 2 mls of 0.5% gelatin (Difco Laboratories, Detroit, MI)
dissolved in PBS (gel-saline) followed by homogenization for 45 seconds with a
microprobe tip of a Virsonic 475 sonicator (Virtis, Gardner, NY). Serial dilutions of the
lung homogenate in gel-saline were used in a standard plaque assay on L-929 cell
monolayers in 6-well tissue culture dishes (Becton Dickinson Labware, Lincoln Park, NJ)
as previously described (Rubin, et al. 1985).
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RNA Preparation

Total cellular RNA was isolated from freshly harvested lungs by guanidinium
denaturation according to manufacturer's instructions utilizing RNazol (Tel-Test Laboratory,
Inc., Friendswood, TX) for RNA work performed in chapters 3 and 4 and Tri-Reagent
(Molecular Research Center, Inc. Cincinnati, OH) for RNA work performed in Chapter 5.

RNA Blot Analysis

RNA was subjected to electrophoresis through a 1% agarose, 7% formaldehyde gel
followed by transfer to nitrocellulose membrane (Schleicher & Schuell, Keene, NH) by
capillary blotting with lOX

sse buffer.

Nitrocellulose membranes were prehybridized in

phosphate buffer (500 mM Na2HP04, pH 7.2, 1 mM EDTA, pH 8.0, 7% SDS, 1% bovine
serum albumin) at 65 0 C for 60 minutes. Incubation was continued for 12-15 hrs. in the
same solution containing the [32P]-labeled probe created by nick translation (Promega,
Madison, WI) of a full length reovirus serotype 3/Strain Dearing M3 gene inserted into a
pUC vector (gift from Dr. Joklik, Duke University, Durham, NC-). The hybridized blots
were washed twice at 65 0 C in buffer containing 40 mM Na2HP04, pH 7.5, 1% SDS and 1
mM EDTA, pH 8.0 for 60 min. The blots were dried and exposed to FUJI RX film at 70 0 C with a Kodak Lanex Regular intensifying screen for 18 hours.
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CHAPTER 3

Respiratory Reovirus IlL Induced Follicular Bronchiolitis:
A Model for the Study of the Lung Inflammation in the
context of the Mucosal Immune System
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Introduction

The mucosal immune system provides the first line of defense against pathogens
which invade at the wet epithelial surfaces of the body (Croitoru and Bienenstock 1994).
These sites include the gastrointestinal (01), respiratory, and urogenital tracts as well as
other wet mucosal surfaces of the body (phillips-Quagliata and Lamm 1994).

The

predominance of immunoglobulin A (lgA) antibodies at mucosal surfaces has allowed the
definition of an interrelated immune response which operates among these mucosal sites
(Tomasi 1992). Thus, immunization at one mucosal site frequently results in the generation
of antigen-specific IgA antibodies at other mucosal sites as opposed to systemic sites
(Phillips-Quagliata and Lamm 1994). The linking of mucosal sites by lymphocytes which
preferentially recirculate to mucosal areas defines the common mucosal immune system.
Since specific IgA antibodies at mucosal surfaces have been correlated with protection
against a number of mucosally related pathogens (Murphy 1994; Underdown and Schiff
1986), knowledge concerning the details of immunity generated at mucosal surfaces is
critical for the control of many human and animal pathogens.
The GI tract has served as a paradigm for the study of mucosal immunity since this
site is thought to be important in the generation of many mucosal immune responses and a
number of distinct lymphoid components can be obtained from this tissue (Kiyono, et ale
1992). Lymphoid populations of the GI tract include lymphocytes contained within the PP
that line the wall of the intestine, lymphocytes contained within the epithelium, and
lymphocytes contained within the lamina propria connective tissue underlying the gut
epithelium (Kiyono, et ale 1992). Specialized epithelial cells (microfold, M cells) present
within the dome epithelium overlying PP facilitate the cytosolic passage of antigenic
material from the intestinal lumen into the PP allowing the sampling of intestinal contents
(Owen 1994). An immune response generated in the PP results in the emigration of primed
lymphocytes into the lymph and circulatory systems (Croitoru and Bienenstock 1994;
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Kiyono, et al. 1992; Phillips-Quagliata and Lamm 1994). Ultimately, the mucosally-primed
immune effector cells home to the mucosal epithelium of the GI tract and may also
potentially seed the lung and other distal mucosal sites (Kiyono, et aI. 1992; Wallace, et ai.
1991).
Organized mucosally-associated lymphoid tissue found in the lung is referred to as
BALT (bronchus associated lymphoid tissue) and is most commonly associated with
branch-points of conducting airways (Bienenstock and Befus 1984). Although organized
lymphoid tissue is not a constitutive feature in human or murine lungs the lymphoid
accumulations along the walls of bronchioles that are characteristic of FB may possess
specialized epithelial cells analagous to M cells in the gut (Bienenstock and Befus 1984;
Pabst 199; Neutra 1996). Lymphatics leading from BALT eventually drain into the lung
associated lymph nodes (LN) where a local immune response may be generated (Morin, et
al. 1994).

While a number of studies have examined the nature of the immune response to
particular mucosal pathogens, many of these organisms are able to colonize and stimulate
specific immunity at only one mucosal site. Thus, it has been difficult to study cross
priming between mucosal sites using the same pathogen. Reovirus serotype l/strain Lang
(reovirus IlL) has been used extensively in our laboratory to study both the cellular and
humoral components of the gut mucosal immune system (London, et al. 1987, 1989, 1990).
In the gut, reovirus IlL induced in PP a B cell response chiefly comprised of reovirus llLspecific IgA+ memory cells (London, et al. 1987) as well as a switch in the
immunoglobulin isotype potential of previously primed, but antigenically unrelated B cells
to IgA (Cebra , et ai. 1989). In addition, MHC restricted, CD8+ virus specific precursor
and effector cytotoxic T lymphocytes (CTL) were present in PP and the epithelium of the
gut mucosa after enteric reovirus IlL infection (London, et al. 1987, 1989).

Therefore,

reovirus IlL is an effective gut-mucosal immunogen eliciting a humoral as well as a cellular
immune response. Since reoviruses are isolates of both the lung as well as the gut (Sabin
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1959), we chose to investigate whether reovirus could serve as an effective respiratory
pathogen which stimulates the appearance of a lymphocytic infiltrate in the lung. In this
report we describe a reovirus IlL-induced murine model of respiratory mucosal immunity
which will allow investigations of the mucosal immune response generated at respiratory
surfaces as well as the interaction between the lung and other mucosal immune sites. In
addition, the follicular organization of the lymphoid infiltrate in the lungs of CD-l mice
following reovirus infection is similar to the subacute human condition termed follicular
bronchiolitis (FB).
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Results

Clinical and pathological observations of reovirus IlL-infected CD-I mice

To assess the affect of respiratory reovirus infection in an experimental animal
model system, CD-I, C3H, and Balb/C mice were observed over time after intranasal (Ln.)
inoculation with 1 X 107 plaque forming units (PFU) of reovirus IlL. This inoculation
dose was selected since we had previously demonstrated this dose to be an effective
stimulus for reovius-specific immune responses in the GJ tract of mice (London, et ale 87).
The viral inoculum was administered in a volume of 30 ,..tI. We determined this was a
sufficient volume to ensure the widespread distribution of the inoculate by Ln. administering
30 J.d of a I: 1000 dilution of india ink to CD-I mice. We then immediately sacrificed the
animal and removed the lungs for gross observation, which demonstrated that the india ink
had been distributed to all regions of the lung (Figure 3.1).

Following reovirus I/L-

inoculation experimental. and control animals were visually monitored for clinical
manifestations of disease over time. No mortality of reovirus IlL-inoculated mice was
observed over an 80 day period of observation.
showed obvious clinical signs of infection.

However, reovirus IlL infected mice

By day 7, experimental animals were

significantly less physically active compared to control saline inoculated mice and these
mice developed a matted, unhealthy coat. These clinical changes were accompanied by a
decrease in body weight which peaked 7 days after inoculation with an average 10% loss of
total body weight versus controls (Figure 3.2A). The mice appeared to resolve the infection
since they regained normal physical activity levels, their coats returned to a nonnal
appearance, and their body weights returned to normal by the end of the third week (Figure
3.2A).
Gross observation of reovirus IlL-infected CD-I mouse lungs revealed a marked
alteration in their appearance during the first two weeks of the infection. As compared to
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Figure 3.1: An India ink colored test inoculum is widely distributed in the lung. A 30 J.lI
volume of India ink, diluted 1: 1000 in water was administered either i. t. or i.n. to CD-1
mice. The animals were then sacrificed immediately and the lungs were removed for
gross observation.
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Figure 3.2. Body and lung weights of reovirus IlL-infected mice. (A) The body weights
of reovirus IlL-inoculated (
•
) and saline inoculated ( - - - 0 - - ) CD-I mice are
represented as the average percentage of the initial body weight at each timepoint. The
initial body weight of an animal was determined by averaging the weight of the animal
during the first three days of the experiment. Data represents the average of at least 6
reovirus inoculated mice and 3 control mice per timepoint with the exception of the control
mice on day 22 where N = 2. (B) The lung weights of two reovirus inoculated mice are
represented at each timepoint.
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control, saline inoculated lungs, reovirus IlL-infected lungs were edematous with pale
subpleural zones alternating with areas of hemorrhage (Figure 3.3). Hyperplasia of the
lung-associated LN occurred during the first week of the infection.

An example of

hyperplastic lung-associated LN 9 days following reovirus infection is shown in Figure 3.3.
In contrast, the lung-associated LN are not observable in control animals (Figure 3.3). This
hyperplasia persisted until at least day 21 (data not shown), Lung weights were detennined
to quantitate the gross pathological changes observed in reovirus IlL-infected mice. These
measurements demonstrated an increase in lung weights which peaked on day 11 with an
approximate 2.5 fold increase in weight as compared to control lungs (Figure 3.2B).
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Figure 3.3: Gross pathology of reovirus IlL-infected lungs. (A) Saline inoculated control
lung. (B) Reovirus IlL-infected lungs 9 days after inoculation. Hyperplastic lungassociated lymph nodes, unobservable in saline inoculated control lungs (A) are shown in
reovirus infected lungs (B, arrow).
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Figure 3.4. Detection of reovirus replication in the lungs of CD-I mice. Northern analysis
was performed using a [32PJ-Iabeled probe derived from the full length reovirus M3 gene
on total cellular RNA from lungs of reovirus IlL-infected or saline inoculated control mice.
Lane 1, uninfected control; Lane 2, day 1 post inoculation; Lane 3, day 2 post inoculation;
Lane 4, day 3 post inoculation; Lane 5, day 4 post inoculation; Lane 6, day 5 post
inoculation; Lane 7, day 6 post inoculation; Lane 8, day 7 post inoculation; Lane 9, day 14
post inoculation.
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Figure 3.5. Detection of reovirus replication in the lung of C3H mice. Northern analysis
was performed using a [32PJ-Iabeled probe derived from the full length reovirus M3 gene
on total cellular RNA from lungs of reovirus IlL-infected or saline inoculated control
mice. Lane 1, uninfected control; Lane 2, day 1 post inoculation; Lane 3, day 2 post
inoculation; Lane 4, day 3 post inoculation; Lane 5, day 4 post inoculation; Lane 6, day 5
post inoculation; Lane 7, day 6 post inoculation; Lane 8, day 7 post inoculation; Lane 9,
day 14 post inoculation.
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Figure 3.6. Infectious virus titers of the lungs of reovirus llI...-infected CD-l mice. The
average +/- S.E. number of plaque forming units (PFU) per whole lung was determined
from the lungs of three mice per timepoint. *No plaques were detected at the limit of
detection (50 PFU/lung) from the lungs of saline inoculated controls or from the lungs of
reovirus llI...-inoculated mice 14 days after infection.
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Histopathological alterations in reovirus IlL-infected CD-I mouse lungs

Histological observations of reovirus IlL-infected or control CD-I lungs were made
on H&E stained paraffin embedded lung sections. By day 6 numerous foci of edema
accompanied by mononuclear cell infiltration (Figure 3. 7B) were observed as compared to
control saline inoculated lungs (Figure 3.7A). Few neutrophils, eosinophils, or mast cells
were observed. The cellular infiltrate was primarily located in the peri-bronchiolar alveolar
spaces and became more tightly condensed by day 11 (Figure 3.7C). At three weeks much
of the edema and original cellular infiltrate had disappeared (Figure 3.7D).

However,

peribroncholar lymphoid follicles indicative of the condition "follicular bronchiolitis" had
formed (Figure 3.7D, arrows).

Normal bronchioles, alveolar ducts, and alveoli can be

observed in control saline inoculated lung tissue (Figure 3.7A).
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Figure 3.7. Histological characterization of the lung of reovirus IlL-infected CD-l mice.
H&E staining was performed on formalin-fixed, paraffin-embedded lung sections. (A)
Saline-inoculated controls; (B) 6 days post reovirus inoculation; (C) 11 days post reovirus
inoculation; and (D) 21 days post reovirus inoculation. All photographs were taken at
100X magnification.
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Observation at a higher magnification was used to reveal the mononuclear
characteristics of the interstitial and intra-alveolar infiltrate in the lungs of CD-l mice. Two
distinct yet overlapping processes were observed following reovirus IlL infection. The first
and predominant process involved the generation of cellular damage in the interstitial and
alveolar spaces during the inflammatory response initiated by reovirus infection. At day 6
proteinaceous residue of pulmonary edema was present in the airspaces (Figure 3.8A). In
addition, nuclear fragmentation was observed in active inflammatory lesions (Figure 3.8A,
arrow). A Gordon and Sweet reticulin stain (GSR) demonstrated most of the alveolar
supporting reticulin was intact with only occasional evidence of fragmentation of the
reticulin framework (Figure 3.9B, arrow). It was also evident by GSR staining that the
alveoli were filled with and expanded by a cellular infiltrate (Figure 3.9B). In addition to the
largely lymphocytic population that had been observed throughout the infection, at day 11
large numbers of macrophages were also found in the airspaces and interstitium (Figure
3.9C, small arrows). Surfactant secreting alveolar type II cells were also observed to be
enlarged at day 11 (Figure 3.9C, large arrows). At three weeks, prominent peri-bronchiolar
interstitial lymphoid follicles were present (Figure 3.9D) and foamy macrophages could be
observed in the air spaces (Figure 3.9D, arrows).
The second process was evident later in the infection and is characterized by an
association of plasma cells with the vasculature of the lung. At day 11 lymphocytes were
present adjacent to the pulmonary arteries in the lymphatic and connective tissue spaces
(Figure 3.9A, arrows). By day 21, the lymphatic and connective tissue space adjacent to the
pulmonary arteries contained cells predominantly of a plasmacytic nature
(Figure 3.9B, arrows).
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Figure 3.8. Histological characterization of the reovirus IlL-induced inflamatory infiltrate
in CD-l mice. (A) H&E staining at 11 days post reovirus inoculation showing lymphoid
populations in the connective and lymphatic tissue (arrows) adjacent to a pulmonary artery
(PA); (B) H&E staining at 28 days post reovirus inoculation showing plasma cells (arrows)
adjacent to a pulmonary artery (PA). Both photographs were taken at 400X magnification.
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Figure 3.9. Histological characteristics of the lymphoid plasmocytic reaction to reovirusIlL infection in CD-l mouse lungs lung. (A) H&E staining showing nuclear fragmentation
(arrow) at 6 days post reovirus inoculation; (B) GSR staining showing minor reticulin
damage (arrow) at 5 days post reovirus inoculation; (C) H&E staining showing increased
number of macrophages in the airspaces (small arrow) and swollen alveolar type II cells
(large arrows) at 11 days post reovirus inoculation; (D) H&E staining showing foamy
macrophages (arrows) at 28 days post reovirus inoculation. All photographs were taken at
400X
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Immunohistochemical localization of lymphocyte populations in reovirus IILinfected lungs

Immunohistochemistry was used to examine the phenotype of the cells infiltrating
the lungs after reovirus IlL infection. Saline inoculated mice were used as controls. At day
6 of the infection CD4+ (Figure 3.10B) and CD8+ (Figure 3.IOD) lymphocytes were
diffusely scattered throughout the lesion and had infiltrated into the interstitial and alveolar
spaces. CD4+ (Figure 3.IOA) and CD8+ (Figure 3.10C) lymphocytes were not observed
in saline inoculated control lungs. In addition to a T cell response, a B cell infiltrate was
observed in reovirus IlL-infected lungs (Figure 3.IOF).

Although B220+ lymphocytes

could be found scattered throughout all compartments of the lung, the majority of B220+
lymphocytes surrounded the pulmonary arteries accompanying the conducting airways
(Figure 3.IOF). B220+ lymphocytes were not observed in saline inoculated lungs (Figure
3.10E). In comparison to the resident alveolar macrophage population found in the air
spaces of control lungs (Figure 3.10G), a large increase in the number of Mac 1+ cells was
observed in reovirus IlL-infected lungs (Figure 3.IOH). These Mac-l + cells were more
numerous, phenotypically larger and more irregularly shaped (Figure 3. IOH) than the
Mac-1 + cells of the control lung (Figure 3.100).
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Figure 3.10: Immunohistochemical analysis of the reovirus induced cellular
infiltrate in CD-I mice. Frozen sections prepared from coptrollungs 6 days
post saline inoculation were stained with: (A) anti-CD4 ; (C) anti-CD8 ; (E)
anti-B220 ; and (G) anti-Mae-I. Identically treated lungs 6 days post
reovirus IlL-infection were stained with: (B) anti-CD4 ; (D) anti-CD8 ; (F)
anti-B220 ; and (H) anti-Mae-I. The sections were counterstained with
Hematoxlyn after the immunostaining procedure. All photographs were
taken at 400X magnification.
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Discussion

Reovirus infection of the GI tract has provided a useful model for addressing
fundamental questions of gut mucosal immunity (London, et al. 1987, 1989, 1990).
Although the immune response at the mucosal surfaces of the lung has been studied
extensively by utilizing various microbial models of infection (Allan, et al. 1990; Graham, et
al. 1991, Hou, et al. 1992, Murphy 1994), the majority of these models have been limited by
the microorganism's restricted immunogenicity to a single mucosal site. Therefore, it has
been difficult to study the interaction of the respiratory and gut-mucosal immune systems in
response to a single pathogen. In this report we demonstrate that respiratory reovirus
infection elicits an acute lymphocytic inflammatory infiltration of the lung and hyperplasia
of the lung-associated LN. Thus, respiratory reovirus infection provides a useful model for
the study of respiratory-mucosal immunity and the relationship of respiratory and gutmucosal immunity to the common mucosal immune system".
H

Since the characterization of the Reoviridae family of viruses as respiratory and
enteric isolates (Sabin 1959), a number of reovirus strains were found to induce pathology
of a number of organs systems including the eNS, heart, pancreas, and thyroid (Sharpe and
Fields 1985; Onodera and Awaya 1990; Sherry 1993; Yukawa 1993). During the 1960s
and early 1970s the effect of reovirus infection of the respiratory tract was studied by
several investigators.

These early studies demonstrated that the i.n. application of

mammalian or avian reovirus strains to newborn or weanling mice resulted in the
establishment of a respiratory infection (Hobbs 1965, Klein, et al. 1967 Stanley 1974).
Delayed bacterial clearance from reovirus-infected lungs was also demonstrated in these
studies (Klein, et al. 1967, 1969). Recently, it has been reported that reovirus enters the
BALT of rats via M cells in a manner analogous to the entry of reovirus into the PP of the
gut (Morin, et al. 1994). While the histopathology of reovirus infection was not addressed
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in this study, reovirus virions were observed associated with type 1 alveolar epithelial cells
suggesting that infection of the lung epithelium and viral replication may occur at this site.
We have found that Ln. inoculation of CD-l mice with reovirus IlL results in a
severe acute viral bronchopneumonia that is histologically similar to the murine model of
respiratory syncytial virus infection (Connors, et ale 1992, Murphy 1994).

The most

obvious characteristic of the reovirus IlL induced respiratory disease is an intense
mononuclear inflammatory infiltrate related to small bronchioles and pulmonary arteries.
This disease pattern can be divided into two overlapping processes.

The first and

predominant process is characterized by an inflammatory response in the airspaces and
interstitium of the lung. The peri-bronchiolar location of the inflammatory infiltrate, which
can be visualized as early as day 3 of the infection, coupled with the observation of nuclear
fragmentation at this site several days later suggests that viral infection and replication
occurs in this region of the lung. As the infection progresses, the initially diffuse cellular
infiltrate becomes more focused around small bronchioles. Although the airspaces become
packed with lymphocytes, the reticulin framework of the lung remains largely intact. While
viral replication diminishes during the later part of the first week of the infection, and
infectious virions are eliminated during the second week, the acute phase of the
inflammatory response persists and continues to organize during this time.

Within the

lesion a second process occurs resulting in the accumulation of plasma cells in the
lymphatic and connective tissue adjacent to pulmonary arteries. As this second cellular
event progresses, the original infiltrate concurrently becomes more condensed and
organized, primarily around bronchioles, and includes an increasing number of
macrophages. By the third week, foamy macrophages, indicative of macrophage mediated
clearance of cellular debris and edema, are present in airspaces and terminal bronchioles.
We also demonstrate the probability that the potent lung inflammatory response
induced by reovirus IlL is not simply a nonspecific reaction to viral infection or damage to
the alveolar epithelium. First, the absence of a potent inflammatory lung response by CD-1

54
mice after i.n. inoculation with reovirus 310 demonstrates that the respiratory reovirus
model of lung inflammation is reovirus serotype specific. In addition, by moving the model
of respiratory reovirus IlL infection to outbred mouse strains Balb/C and C3H we show
that the genetic background of the host animal may influence the intensity of the
inflammatory response to reovirus IlL. Intranasal inoculation of Balb/C mice with reovirus
IlL induces a pattern of pulmonary inflammation that closely parallels the peri-bronchiolar
accumulation of mononuclear cells observed in CD-I mice after Ln. inoculation with
reovirus IlL. However, the pulmonary response of C3H mice to Ln. inoculation with
reovirus IlL is considerably less severe and does not result in the prominent FB-like
organization of infiltrating mononuclear cells.

Although the variability observed in the

reovirus IlL-induced pUlmonary responses among CD-I, Balb/C, and C3H mice may seem
to indicate that infectious reovirus IlL would be cleared from the lung with kinetics that
would be directly related to the intensity of the inflammatory response, assessment of viral
replication by northern analysis indicates that the reovirus replication kinetics are similar
between the strains.

In situ immunohistochemical analysis of reovirus-infected CD-I lungs was
performed to characterize the composition of the cellular infiltrate of the lung. This analysis
revealed the presence of CD4 + and CD8+ T -lymphocytes, B-Iymphocytes, and
macrophages in the airspaces and interstitial tissues of reovirus IlL-infected lungs. Thus,

any of these cellular populations may be involved in either the clearance of the viral infection
and/or be associated with the persistence of the inflammatory infiltrate.

Clearance of

infectious viruses from the lung is frequently associated with a CTL response mectiated by
MHC class I restricted CD8+ T lymphocytes (Allan, et ai. 1990; Hou, et al. 1992; Taylor,

et al. 1985). It is possible that the CD8+ lymphocytes infiltrating reovirus-infected lungs
are performing an analogous function. Our observation that infectious reovirus virions are
cleared with similar kinetics to that observed in experimental influenza and Sendai virus
infections (Eichelberger, et al. 1991; Hou and Doherty 1995) may support this hypothesis.
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In addition, we have demonstrated lysis of reovirus-infected target cells by both pulmonary
and lung-associated LN lymphocytes obtained from reovirus-infected but not normal Balb/c
mice (Thompson, et al. 1996). The function of CD4 + helper T cells in the mediation of
viral clearance from the lung is unclear, making their role in lung immunity difficult to
assess (Allan, et al. 1990; Connors, et al. 1992). In vivo depletion of CD4 + cells in the
influenza model only delays the clearance of influenza virus by four days (Allan, et al.
1990), although the CD4 + population also appears to be a primary source of TH2
associated cytokines (Sarawar and Doherty 1994). Conversely, in vivo depletion of CD4 +
but not CD8+ cells abrogates the histopathology observed in respiratory syncytial virus
infected mice (Connors, et al. 1992). The role of the CD4+ T lymphocytes in reovirus
infected lungs remains to be determined.
Although the humoral component of the respiratory reovirus III response in this
model has not been investigated, the presence of B220+ cells adjacent to pulmonary arteries
during the first week of infection and the appearance of plasma cells at the third week in the
same location suggests that a reovirus-specific component of the pulmonary B cell response
is occurring. If reovirus-specific B cells exist in the lung, they may either be locally
generated or be the progeny of viral-specific B lymphocytes which have emigrated from the
lung-associated LN. Most investigations of the humoral immune response in the lung
indicate that IgO is the predominate isotype in lower respiratory tract secretions (Reynolds,
1991).

One group, however, reports that IgA predominates over other isotypes in an

experimental influenza model (Fazekas, et al. 1994). It will be of interest to determine the
isotype profile of reovirus-specific antibodies in the lung and to correlate the isotype profile
of reovirus-specific antibodies of the lung and gut after various mucosal routes of
immunization.
Respiratory reovirus infection generates a potent mucosal inflammatory response
that makes reovirus a suitable probe for respiratory mucosal investigations. The results
reported in this chapter suggest that reovirus can be used to develop a practical model of
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respiratory mucosal immunity that will contribute to an understanding of the pulmonary
immune response and more broadly, its relationship to the common mucosal immune
system. Most importantly this model will provide an opportunity to compare immune
responses to the same immunogen at remote mucosal surfaces, namely between the lung
and GI tract. In addition to these applications, respiratory reovirus infection provides a
potentially useful model for the study of a spectrum of inflammatory lung diseases. The
follicular organization of the lymphoid infiltrate in the lungs of CD-l mice following
reovirus infection is similar to the human condition termed follicular bronchiolitis (FB). FB
is characterized by enlarged peri-bronchiolar lymphoid follicles that restrict airflow by the
compression of the bronchioles (Wells and du Bois 1993).

In humans FB may be

associated with environmental factors such as viral infections or the inhalation of tobacco
smoke (Wells and du Bois 1993). Additionally, FB may be a component of systemic
disorders with a predilection for connective tissue diseases which are characterized by
increased fibroblast activity and matrix deposition (Myers and Colby 93, Wells and du Bois
93). Additionally, as addressed in the subsequent chapter, I observed that CBAI] mice in
response to respiratory reovirus IlL infection develop the intraluminal fibrotic syndrome
Bronchiolitis Obliterans Organizing Pneumonia (BOOP), or the acute inflammatory
disorder, Acute Respiratory Distress Syndrome (ARDS) (Bellum, et al. 1997). BOOP, and
ARDS, like FB, are considered to belong to a spectrum of lymphocytic inflammatory
diseases of the small aitways of the lung (Myers and Colby 1993; Wright, et al. 1992).
However, BOOP is characterized by the formation of intraluminal fibroblastic plugs in
terminating bronchioles, alveolar ducts, and airspaces in addition to the usual presence of an
organizing lymphocytic (Myers and Colby 1993). The development of ARDS also has
underlying similarities to the generation of FB and BOOP, but is primarily characterized by
extensive vascular damage that results in the flooding of the air spaces with edema (Myers
and Colby 1993; Wright, et al. 1992).

While BOOP, ARDS and FB are different

syndromes which to date have not been linked in a causal relationship, our results suggest
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that comparative differences in the respiratory response to reovirus among strains of mice
could be used to investigate relationship of FB and BOOP as a continuum of inflammatory
lung disease.
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CHAPTER 4

Respiratory Reovirus IlL-Induced Bronchiolitis Obliterans
Organizing Pneumonia: A Model for the Study of
Bronchoalveolar Intraluminal Fibrosis
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Introduction

Acute, inflammatory responses that occur in the distal air spaces of the lung
(bronchioles, alveolar ducts, and alveoli) may develop into one of a limited number of
nonspecific pulmonary disorders characterized by fibrosis (Cordier, et al. 1994; Myers, et
al. 1994; Katzenstein and Askin 1990; Kuhn, et ale 1989). The pathologic features of a

fibrotic response in the lung may include interstitial collagen deposition as observed with
usual interstitial pneumonia (VIP), interstitial fibroblast proliferation as observed with
diffuse alveolar damage (DAD), or intraluminal fibroblast proliferation as observed for a
relatively recently described disorder termed bronchiolitis obliterans organizing pneumonia
(BOOP) (Myers, et ai. 1994; Epler, et al. 1985), BOOP lesions have a patchy distribution

in the lung, are frequently associated with a peri-bronchiolar organizing pneumonia and also
with the presence of lipid - laden foam cells in the alveolar spaces (Colby 1992). The
structural integrity of alveolar ducts and walls within regions of BOOP lesion development
are normally preserved; however, the alveolar septa may be thickened with an infiltrate of
inflammatory mononuclear cells (Colby 1992). Since the initial description of BOOP by
Epler and co-workers in 1985, an increasing number of reports of BOOP have appeared in
the literature and BOOP is now accepted as a distinct clinical syndrome. While it has been
documented that BOOP lesion development can be a secondary disorder to a number of
pulmonary infections (which are frequently believed to be viral), most BOOP cases are not
associated with any identifiable pathogen and are classified as idiopathic BOOP (Kuwano,
et al. 1990; Epler 1992).

Furthermore, a smaller group of BOOP cases have been

associated with toxic fume exposure, connective tissue disorders, and as a clinical
complication associated with a subset of lung and bone marrow transplantation (Myers, et
al. 1994; Martinez and Lynch 1994; Mathew, et ale 1994; Thirman, et al. 1992). BOOP is

normally treated with corticosteroids; however, some patients experience a spontaneous
remission of BOOP and approximately one third of patients that have been administered
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corticosteroids still show evidence of BOOP lesions at the end of treatment (Izumi 1994).
Additional recent literature also suggests that not all BOOP cases respond well to steroids
and that BOOP can be fatal in a small subset of cases (Nizami, et ai. 1995; Epler 1995)
Although BOOP is a well established syndrome, a small animal model developed for
investigations of BOOP lesion development has not been described in the literature.
Therefore, little is known concerning the cellular and molecular mechanisms that mediate the
formation and resolution of BOOP lesions. Although existing models of experimental
pulmonary fibrosis have been useful for histopathological and functional investigations of
other types of fibrotic events in the lung, they fail to accurately reflect the intraluminal and
fibroblastic nature of the bronchoalveolar obliteration observed in BOOP lesions (Piguet, et

al. 1990; Zhang, et al. 1996). Therefore, while these models are of interest for the study of
interstitial lung fibrosis or collagen scarring they are not directly relevant for the study of
BOOP. This chapter describes the first virus-induced model of BOOP in which CBAlJ
mice are intranasally (Ln.) inoculated with reovirus IlL and subsequently develop BOOP
lesions, which morphologically resemble BOOP in humans. These BOOP lesions, like
those observed in humans, are characterized by the patchy distribution of intraluminal plugs
of granulation tissue that appear to be chiefly composed of fibroblast like cells and by
limited collagen deposition. The development of BOOP lesions 'in this animal model is
preceded by a similarly patchy distribution of peri-bronchiolar mononuclear cell
inflammatory lesions which progress into characteristic well developed BOOP lesions
during the second and third week post infection.
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Results

Respiratory reovirus tIL infection of CBAlJ mice· induces intraluminal fibrotic
lesions

We have previously described the pulmonary inflammatory response of CD-l and
Balb/c mice after the intranasal inoculation of 1 x 107 PFU of reovirus IlL (Bellum, et al.
1996, Thompson, et al. 1996). Both strains responded with a well delineated, peribronchiolar lymphocytic inflammatory response with 100% of the experimental animals
surviving the infection. In contrast, the intranasal inoculation of CBAlJ mice with 1 x 107
PFU of reovirus reovirus IlL resulted in a severe clinical illness characterized by extensive
damage to the lung vasculature and resulted in a mortality rate approaching 90% in the
second week after reovirus IlL inoculation (Table I, chapter 5). This acute pattern of
inflammation recapitulated the human small airway disease termed acute respiratory distress
syndrome (ARDS). When the lungs of surviving mice were examined histologically, we
observed the presence of lesions which were similar to those observed in humans and
characterized as bronchiolitis obliterans organizing pneumonia (BOOP). In Figure 4.1, a
well formed BOOP lesion 21 days after reovirus IlL infection of CBAlJ mice is shown. In
this figure a characteristic fibrous cellular plug is present in an alveolar duct, which indicates
the lesion has a proximal acinar location in the lung. As shown in this figure, these wellformed lesions are frequently present in areas of the lung which are otherwise histologically
unaffected and normal.
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Figure 4.1. Histologic characterization of a well fonned BOOP lesion. H & E staining of
a characteristic fibrous cellular plug found in an alveolar duct at 21 days post i.n.
inoculation with 1 x 107 PFU of reovirus IlL. Objective magnification, X 20.
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Histopathological Analysis of the Temporal Development of BOOP Lesions in
CBAlJMice

While we have demonstrated the presence of BOOP lesions in CBNJ mice 21 days
after respiratory reovirus IlL infection, a particular advantage of this model system is the
ability to study the development of such lesions over time after the initiation of a known
viral infection. These studies clearly demonstrate that the formation of BOOP lesions are
preceded by a patchy inflammatory mononuclear cell infiltrate that progressively becomes
more organized during the first three weeks of the infection. A kinetic analysis of the
formation of BOOP lesions in CBNJ mice is shown in Figure 4.2. In Figure 4.2A, the
response to reovirus IlL at day 7 is typically characterized by an inflammatory cellular
infiltrate that demonstrates a typical focus of an active viral pneumonia.

At day 7, the

cellular infiltrate is characterized by mononuclear cells and macrophages that are in the air
spaces and the interstitium (Figure 4.2A).

An analysis of lung sections at low power

demonstrates that these diffuse inflammatory infiltrates have a patchy distribution
throughout the lung and that these are often in a proximal acinar location (data not shown).
At day 14, an increase in the number of macrophages and the formation of condensed focal
lymphocytic accumulations are observed (Figure 4.2C, arrow).

At day 21 the

peribronchiolar mononuclear infiltrate is characterized by a more prominent lymphocytic
proliferation (Figure 4.2E, arrows).

The infiltrate at day 21 is still present in the

interstitium and airspaces, including the presence of intra-alveolar macrophages.
In addition to the mononuclear cell inflammatory response, the development of fibrotic
lesions can also be observed to occur during the three week time course of the infection. At
day 7, the proximal acinar development of young fibrous polyps of collagenous tissue (FP)
can be observed (Figure 4.2B). While these types of lesions are not commonly found

at

day 7, when present, they demonstrate that proliferative fibroblastic lesions can develop in
association with an area containing an inflammatory infiltrate both within the alveolar spaces
and within the interstitium (Figure 4.2B). At day 14, young fibroblastic polyps continue to
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organize in the air spaces and foamy macrophages (arrow)

~

observed in the air spaces

surrounding the lesion (Figure 4.2D). The relationship of this lesion to a small pulmonary
artery (PA) indicates that the location of the lesion in the lung is proximal acinar (Figure
4.2D). The fibroblastic polyps appear to develop simultaneously in tenninal bronchioles,
alveolar ducts, and alveolar spaces. In contrast to humans, respiratory bronchioles (RB) are
typically absent in mice, and when present, are poorly developed and defined by the
presence of only a few ciliated bronchiolar epithelial cells. {phalen 1984) The location of
fibroblastic polyps observed in this model include regions of the acinus analogous to RB in
humans. The further development of these lesions can be observed at day 21 where a well fonned fibroblastic polyp is observed in an alveolar duct (Figure 4.1 and 4.2F).
In contrast to the above described pattern of the development of mononuclear cell
inflammatory infiltrates and BOOP lesions, control mice inoculated with saline do not
develop an observable inflammatory (Figure 4.2G). Infectious reovirus virions are required
to initiate the inflammatory response and the development of fibroblastic lesions. This is
demonstrated by the inoculation of CBAlJ mice with a non-replicating preparation of
reovirus 11L (produced by exposure of infectious virions to a UV light source) which
contains less than 5 PFU/ml of infectious virions as detennined by titration on L-929
fibroblast mono layers (data not shown),

CBAlJ mice inoculated with non-replicating

virions do not develop an observable inflammatory response (Fig. 4.2H).
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Figure 4.2. Temporal analysis of the pulmonary inflammatory response and fibrotic
reaction as shown by H & E staining after i.n. inoculation with 1 x 107 PFU of reovirus IlL.
The inflammatory mononuclear cell infiltrate, which is initially diffuse at day 7 post
inoculation (A), is characterized by condensed lymphocytic accumulations (arrow) at day 14
(C), and by more prominent peribronchiolar lymphocytic proliferation (arrows) at day 21
(E). The stages of development of fibroblastic lesions include the association of young
fibrous polyps (FP) at day 7 (B), the continued organization of FP in air spaces and
observation of foamy macrophages (arrow) at day 14 post inoculation (D). The proximal
acinar location of the lesion is indicated by the relationship of the lesion with a pulmonary
artery (PA). At day 21 post inoculation well formed fibroblastic polyps are observed in
alveolar ducts (F). Saline inoculated (G) and UV inactivated reovirus IlL (H) controls are
shown 7 days post inoculation. Objective magnification, X 10.(A, C, and E) and X 20 (B,
D, F, G, and H).
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To further characterize the nature of the cellular response in this model, Verhoeff Van
Gieson (VVG) - stained, paraffin embedded lung sections were analyzed since this elastic
tissue stain allows a better appreciation of the architecture of the lung.

At 7 days, the

cellular infiltrate, which is chiefly composed of lymphocytes and macrophages, is present in
the interstitium, alveolar spaces, and alveolar ducts (Figure 4.3A). In Figure 4.3A, a cuff of
mononuclear cells is observed around a pulmonary artery (PA). At day 14, fibrous tissue
(F) is observed in the alveolar ducts and alveoli (Figures. 4.3B and 4.3C). When these
images are viewed in color, pink staining collagen can be discerned morphologically in the
fibrous tissue shown in Figure 4.3C. Elsewhere at this time the cellular accumulation has
become more histiocytic and more fibrous

(Figures. 4.3B and 4.3C).

By day 21,

prominent clustering of foamy macrophages in the air spaces associated with BOOP lesions
is observed (Figure 4.3D).
A Gordon and Sweets stain for reticulin (GSR) was performed on paraffin - embedded
reovirus IlL infected lung sections to detect changes in the supporting architecture of the
lung during the development of BOOP lesions (Figure 4.4). At day 14, reticulin-containing
organizing fibrous tissue in alveolar ducts is observed (Figure 4.4A, arrow). In addition,
reticulin fibers are observed in close association with clusters of macrophages within the
airspaces of BOOP lesions (Figure 4.4B, arrow).
Hyperplasia of the lung associated lymphoid tissue is also a feature of the inflammatory
response to respiratory reovirus IlL infection. The lung associated lymphoid tissue at 7
days post reovirus IlL inoculation is present in small amounts about a core of adipose
tissue in the hilum of the lung (Figure 4.5A). By day 14, the lung associated hilar lymphoid
tissue shown in figure 4.5B at the identical magnification as figure 4.5A, had undergone
dramatic lymphoid hyperplasia increased in size and is densely packed with lymphocytes
(Figure 4.5B). Germinal centers (GC) are also present in the lung associated lymphoid
tissue at day 14 (Figure 4.5B).
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Figure 4.3 Further histologic characterization of the cellular response in CBA/J mice
induced by 1 x 107 PFU of reovirus-IlL. VVG staining shows a cuff of mononuclear cells
around a pulmonary artery (PA) adjacent to a bronchiole (Br) at day 7 post inoculation (A).
Fibrous tissue (F) at day 14 (B) and fibrous tissue with collagen also observed at day 14
(C) are found in alveolar ducts and alveoli. Clustering of foamy macrophages in air spaces
associated with BOOP lesions at day 21 (D).
Objective magnification, X 40.
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Figure 4.4. Histologic characterization of alterations in lung architecture in CBAlJ mice
after inoculation with 1 x 107 PFU of reovirus IlL. GSR staining at day 14 post
inoculation shows reticulin containing fibrous tissue (arrow) in alveolar ducts (A) and a
close association of reticulin fibers (arrow) with macrophages (B).
Objective magnification, X 10 (A) and X 64 (B).
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Figure 4.5. Histologic characterization of lung associated lymphoid tissue hyperplasia frpm
a CBAlJ mouse after inoculation with 1 x 107 PFU of reovirus IlL. H & E staining of hilar
lymphoid tissue at day 7 post inoculation (A) and at day 14 with a genninal center (GC)
shown (B).
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Ultrastructural Characterization of BOOP Lesions

Transmission electron microscopy (TEM) was used to examine BOOP lesions in
the lungs of CBAlJ mice 19 days post reovirus inoculation (Figure 4.6).

The electron

microscopic view of the BOOP lesion in Figure 4.6A depicts the extension of a collagenous
lesion (Col) into the air space, which is defined by an epithelial type I cell (E, center of field)
and a type II cell (IT, left center).

The cellular processes of fibroblasts (F) that have

interdigitated into the collagen bundles can also be observed in the lesion (Figure 4.6A). A
pulmonary epithelial cell (E) lines the alveolar extension of the fibrotic (BOOP) lesion and
an alveolar macrophage (M) is also present (Figure 4.6A). Figure 4.7B shows another ultra
structural feature of a BOOP lesion. In this electron micrograph, long strands of young
fibroblast processes can be seen embedded in a matrix of glycosaminoglycans (GAG)
(Figure 4.6B). Macrophages are also present in close association with fibroblasts and the
extracellular material of this lesion (Figure 4.6B),
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Figure 4.6. Ultrastructural characterization of a BOOP lesions. At 19 days after
inoculation with 1 x 107 PFU of reovirus IlL transmission electron microscopy shows a
lesion composed of collagen (Col) and fibroblasts (F) in close association with alveolar
epithelial type I (E) and type II (II) cells, extending into an alveolar space (Alv), (A). A
macrophage (M) and red blood cell (RBC) are also observed. Macrophages (M) and
cellular processes of fibroblasts (F) are found embedded in a matrix of glycosaminoglycans

~~hlhc~~lon, X 6250.
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Immunohistochemical Localization of Reovirus Associated Proteins in
Reovirus tIL - infected Lungs

Immunohistochemistry was used for the in situ identification of reovirus-encoded
proteins in this model. At day 1, a patchy distribution of reovirus-encoded proteins is
observed as a diffuse focus of deposition at low magnification (Figure 4.7A).

Higher

magnification of the same lesion demonstrates positive staining for reovirus proteins in a
large number of cells; however, the precise nature of the cells cannot be determined because
of the intensity of the staining (Figure 4.7B). At day 7, the immunoperoxidase product is
still present on cells that appeared to be macrophages and alveolar epithelial cells (Figure
4.7C). Control lungs stained at 7 days after inoculation with UV - inactivated reovirus IlL
were negative for reovirus associated proteins (Fig. 4.7D).

73

.A' ~ ,
"

--.'

..

.,

•

"

,.- -.. r ",

"

, <r..:t. l

!

.. l!

... 1 .,

...

" C

~

"

,

"

,.

t

~.#

.:...,.

...

\

..

r ..

•1

•

....
If

.,

.I

,."

;1

.-

. .... ~ .~

I

0

.. •

~

,.

"I ~.'

l

0 ,

""~. :~

4.i

,

\

....

}

.

'~

.•"

.. -.f.

~ ""1

'

i'

--

lit

.J I.

~... "If

..I:

.

"

~

•

..

'~

" , .I. , ...

~ oj'

,

J

.

"..

~

Figure 4.7. Immunohistochemical analysis of reovirus - encoded proteins in CBNJ mice
after i.n. inoculation with 1 x 106 PFU of reovirus IlL. Anti-reovirus staining was
performed on frozen sections prepared on day 1 post inoculation, which is shown at low
magnification (A) and higher magnification (B). Staining was also performed at day 7 (C)
and on control lungs at day 7 post inoculation with UV inactivated reovirus IlL (D).
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Clearance of Reovirus tIL from the Lungs of Infected Mice

The clearance of virus from the lungs of mice infected with reovirus IlL was
assessed by a standard plaque assay of lungs homogenized by sonication (Figure 4.8). At
day 1 of the infection the average titer of infectious virions is 6.5 x 106 PFU/lung
representing an approximately 65% increase from the initial viral inoculum of 1 x 106 PFU
The titer increases to 7.5 x 106 PFUIlung on day 3 and drops to 2.7 x 106 PFUllung on day
5. However, at day 7 a 1.5 log decrease of infectious virions is observed (1.2 x 105
PFU/lung) as compared to the titer of infectious virus present on day 5.

By day 21,

infectious virions are not detected within the limits of the assay. Infectious virions are not
observed in homogenized, saline inoculated control lung tissues (data not shown).
Additionally, in a separate experiment reovirus IlL dissemination to tissues other than the
lung also assessed by a standard plaque assay of homogenized spleen and Peyer's Patches
(PP) during a one week time course after i.n. inoculation with 1 x 107 PFU of reovirus IlL.
At day 1 of the infection the average titer of infectious virions in the lung, spleen, and PP
was 2.1 x 108 PFU, 1.7 x 102 PFU and 3.5 x 103 PFU respectively. In lungs the titer
increases slightly to 2.3 x 108 PFU/lung on day 3 and drops to 6.8

X

106 PFU/lung on

day 7. Spleen and PP demonstrate approximately a ten fold increase in infectious virus titer
from day 1 to day 3 after inoculation (spleen, 4 x 103 PFU and PP, 1.5 x lQ4 PFU), but then
on day 7 (spleen, 3.3 x 102 PFU and PP, 5 x 102 PFU) both of these tissues show a return
to titers similar to those observed on day 1.
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Figure 4.8. Infectious virus titers of the lungs of reovirus IlL-infected mice. The average
+ SE number of PFU -per whole lung was detennined from the lungs of three mice per
timepoint. *No plaques were detected at the limit of detection (50 PFUllung) from the
lungs of saline-inoculated controls or from the lungs of reovirus IlL-inoculated mice 21
days after infection.

76

1.09
1.08
~

....=
r.I:J
r.I:J

~

'~

Q.

1.07
1.06

;J
~
~

1.05

~

OJ)

=
'~

~

<

1.04
1.03

1.02
3

7

Days after inoculation
Figure 4.9. Infectious titers of the lungs (D), spleen (II), and Peyer's patches
(D). The average number of plaque forming units (PFU) per whole lung was
determined from the lungs of three mice per timepoint.

77

Discussion

BOOP belongs to a group of lung disorders whose response to acute lung injury is
primarily characterized by fibroblast proliferation within the lumina rather than the
interstitial deposition of collagen observed in other fibrotic lung diseases (Myers, et al.
1994, Katzenstein and Askin 1990).

However, unlike related fibroblast proliferative

disorders such as the interstitial pneumonias and bronchiolitis obliterans, a constrictive
bronchiolar disease, BOOP is distinguished from these by the following features: (i) the
formation of connective tissue polyps in the lumina of distal air spaces; (ii) fibrinous
exudates; (iii) the collection of foamy macrophages in the alveoli; (iv) the infiltration of
alveolar walls with lymphocytes; (v) plugs of myxoid connective tissue in airspace lumina;
(vi) the maintenance of lung architecture (Epler 1992). The current understanding regarding
the development of BOOP is based largely on histopathologic and radiological observations
and on pre-existing knowledge of mechanisms of fibrosis. BOOP is usually detected in
humans as it approaches end stage (Epler, et al. 1985). In this setting, the cellular and
molecular factors that were involved in the fonnation of BOOP can no longer be identified.
While there are existing models of BOOP in the literature, they are either not practical
because the use of large animals is involved, or they fail to accurately parallel the
histopathologic observations of BOOP in humans (Castleman 1985; Fukuda, et al. 1985;
Rhodes, et al. 1989). Since many cases of idiopathic BOOP in humans are believed to be
the sequelae of undocumented viral infections (Kuwano, et al. 1990; Epler 1992), the
development of a small animal model of virus-induced BOOP would aid investigations
concerning the temporal development and resolution of the intraluminal fibroblastic lesions.
A temporal analysis of respiratory reovirus IlL infection in CBAlJ mice
demonstrated that the formation of BOOP lesions is preceded first by a patchy distribution
of reovirus protein expression which is followed by a similar patchy distribution of
inflammatory mononuclear cell infiltrates. These patchy inflammatory infiltrates have a
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proximal acinar location and are initially loosely organized into the typical foci of an active
viral pneumonia. During the three weeks following reovirus IlL inoculation, the initial
mononuclear cell

infiltrate condenses

into

prominent

peri-bronchiolar

lymphoid

accumulations. However, in CBAlJ mice, a second process occurs in which a subset of
lesions become infiltrated with fibroblasts and progress over the three week period into
discrete BOOP lesions.

The pattern of mononuclear cell organization without the

involvement of intraluminal fibrosis, which is observed in CD-1 and Balb/c mice, results in
lesions histopathologically consistent with the non - fibrotic human syndrome termed
follicular bronchiolitis (FB) (Myers and Colby 1993; Wells and du Bois 1993). Since
CBAlJ mice develop similar foci of mononuclear cell organization, our studies reveal that

BOOP lesions occur within a spectrum of inflammatory lung diseases that occur in the
distal air spaces. Our studies with respiratory reovirus infection in different strains of mice
suggest that genetic host factors are critical determinants of the degree of progression of a
pulmonary insult from a primarily inflammatory response (FB) toward a fibrotic response
(BOOP).
Since infiltrating lymphocytes seem to be involved with the initiation of BOOP
lesions (Mukae, et ai. 1995; Costabel, et al. 1992), it is possible that these cells play an
active role in the progression of inflammatory foci into lesions which are progressively
dominated by fibroblasts. The hyperplastic, reactive hilar lymphoid tissue and organizing
lymphocytic peri-bronchiolar accumulations observed after reovirus infection suggest that a
vigorous immune response is elicited in the lung and draining lymph nodes.

We have

previously demonstrated that the organizing lymphocytic peribronchiolar accumulations
consisted of both CD4+ and CD8+ T lymphocytes, B lymphocytes, and increased numbers
of macrophages in CD-l and Balb/c mice (Bellum, et al. 1996; Thompson, et al. 1996). In
Balb/c mice, there is a dominance of CD8+ T lymphocytes in the lung interstitium and
alveolar spaces after respiratory reovirus IlL infection (Thompson, et al. 1996). Lung and
hilar lymph node lymphocyte populations contain virus-specific cytotoxic T lymphocytes
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A comprehensive review of BOOP suggested that BOOP "is a nonspecific mode of
repaIr of parenchymal structures after acute or subacute injury, and thus cannot be
dissociated from the spectrum of inflammatory reactions that have both alveolar epithelial
injury and fibrinous intra-alveolar deposition as a common denominator " (Cordier, et al.
1994). These results describing the comparative differences in the respiratory response to
reovirus infection among strains of mice are in agreement with this model. Thus, it is our
contention that respiratory reovirus infection provides a small animal model to investigate
the relationship of BOOP as a continuum of inflammatory lung disease.
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CHAPTER 5

Respiratory Reovirus l/L-Induced Acute Respiratory
Distress Syndrome: A Model for the Study of the
Immunopathogenesis of Acute Bronchoalveolar
Inflammation
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Introduction

Acute respiratory distress syndrome (ARDS) is a significantly important acute lung
disorder that is characterized by the most severe inflammatory reaction known to occur in
the lungs (Luce 1998). The mortality rate exceeds 50% and generally ARDS is not
responsive to corticosteroid treatment as is BOOP and currently only supportive therapy
such as mechanical ventilation is available to treat ARDS (Rubin and Farber 1994). One of
the most prominent pathological indicators of ARDS is the formation of hyaline membranes
along the basal lamina between the vascular endothelium and the alveolar epithelium (Luce
1998). The formation of these membranes results from the deposition of fibrin, albumin,
cellular debris, and other material that is associated with widespread damage to the
endothelial and epithelial surfaces (Luce 1998). The collapse of physical barriers between
the intraluminal compartment of the alveoli and the vasculature leads to significant edema,
which is a leading cause of mortality among ARDS cases (Luce 1998). Histopathological
of observations of ARDS development in humans and in a rat model of ARDS demonstrate
that the destruction of the vascular endothelium is preceded by damage to alveolar type I
cells (Lamy 1976, Bachofen 1977). The pathogenesis of ARDS also includes infiltration of
lymphocytes into the lung (Luce 1998). However, unlike BOOP and other lung disorders
characterized by a foundation of organizing pneumonia with a patchy distribution in the
lung, the distribution of infiltrating lymphocytes in ARDS is widespread (Luce 1998).
The histopathological alterations that occur in the lung during the development of
ARDS appear to be a generalized acute response to significant destruction of the alveolar
epithelium. This suggestion is indicated by the observation that many of the common
causes of ARDS, including sepsis syndrome (systemic bacterial infection), aspiration of
gastric contents, pulmonary contusions, and near drownings all generate similar pulmonary
pathological changes preceding ARDS (Hudson 1995).

Currently one of the major

obstacles in providing improved treatment modalities for ARDS is the lack of information
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regarding the inflammatory cell populations that mediate the acute inflammatory response in
the lung following alveolar epithelial cell damage (Baughman 1996).

T -lymphocyte

responses have long been observed to be associated with inflammatory responses in the
lung, including ARDS, that are initiated by a wide variety of pathogenic, environmental, and
autoimmune related causes (Kradin, et al. 1986; Costabel, et al. 1987; Hunninghake, et al.
1980; DailI992). However, the role ofT-lymphoctes in acute inflammatory reactions in the
lung have not been clearly defined (Kumar and Lykke 1995).

Our laboratory has

characterized a model of ARDS in CBAlJ mice following respiratory reovirus IlL infection.
In this model approximately 40% of the infected animals develop an acute pulmonary
inflammatory reaction during the second week of infection that recapitulates the
histopathological features of ARDS described in humans. The mortality rate of CBAlJ
mice that develop ARDS in this model is 100%. Those animals that do not develop ARDS
survive and develop BOOP lesions. The contribution of T lymphocytes in the pathogenesis
of ARDS in this model was examined by inducing a respiratory reovirus IlL infection in
CBAlJ mice that were rendered T lymphocyte deficient by neonatal thymectomization. This

approach demonstrated that none of the neonatally thymectomized (NTx) CBAlJ mice
experienced an acute and deadly pulmonary inflammatory response to reovirus that is
associated with ARDS. However, Ntx CBAlJ mice still developed-the intraluminal fibrosis
that typifies BOOP lesion formation
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RESULTS

Respiratory reovirus tIL infection alternatively induces ARDS in a subset of
CBAlJ mice

Histological characterization was perfotmed on H&E stained fotmalin-fixed paraffinembedded lung sections from CBAlJ mice that died of ARDS related causes 12 days post
reovirus IlL infection (Figure 5.1). The reovirus-induced pulmonary cellular infiltrate was
chiefly composed of mononuclear cells and contained relatively few macrophages or
PMNs. Overall, the cellular infiltrate was diffuse, but had demonstrated a degree of periacinar organization (near bronchiolar divisions) (Figure 5.2A).

Evidence of impaired

circulation as a potential consequence of vascular damage included the observation of dense
collections of compacted red blood cells (RBCs) (stained bright red) in the lung capillaries
(Figure 5.2A). Higher magnification of the lung vasculature demonstrated the fotmation of
hyaline membranes on damaged alveolar walls (Figure 5.2B). Typically hyaline membranes
are composed of dead cellular debris and serum proteins like albumin that are all joined
together in a fibrin matrix (Katzenstein, et ala 1976). Their presence is considered to be a
hallmark histopathological feature of ARDS (Katzenstein and Askin 1990).

ARDS development in CBA/J mice following reovirus inoculation is dose
dependent

Since an inoculum dose of 1 x 107 PFU of reovirus IlL resulted in a high mortality
rate from ARDS in CBAlJ, we examined the effect of decreasing inoculum doses of
reovirus IlL on the generation of BOOP lesions in additional experiments. In these studies
we found that if a 1 log decrease in the viral inoculum dose was used, the percentage of
CBAlJ mice that died from ARDS-related causes dropped from 90% to 40% (Table 5.1).

All of the surviving mice still developed BOOP lesions that were indistinguishable from
those observed in mice inoculated with 1 X 107 PFU. Mice inoculated with 1 X 105 PFU or
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1 x 1()4 PFU of reovirus had a 100% survival rate but did not generate severe inflammatory
lesions nor did they generate pronounced fibrotic BOOP lesions (Table 5.1).
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Figure 5.1. Respiratory reovirus IlL infection induces ARDS in a subset of CBAlJ mice.
H & E staining shows accumulation of mononuclear cells and PMNs in the interstitial

and al v.eolar tiss.ue .

UbJectIve magnltlcatIon, X 20.
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A

B

Figure 5.2. Histologic characterization of acute respiratory distress syndrome (ARDS) in
the subset of CBA/J mice that do not develop BOOP following respiratory reovirus I/L
infection. H & E staining shows the over-accumulation of red blood cells (RBCs) in the
capillaries of the lung (A, red staining). Higher magnification demonstrates the presence of
proteinaceous edema in the vasculature (B, large arrow) and the development of thick
hyaline membranes along the walls of the lung vasculature (B, small arrow).
Objective magnification, X 10 (A) and X 20 (B).
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Table I

Inoculum
(PFU reovirus)

% Survivors

107

10

106

60

105

100

104

100
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Histopathological characterization of the lungs of neonatally thymectomized
CBAlJ mice following respiratory reovirus infection
Confinnation of the T-Iymphocyte deficiency generated by neonatal thymectomy
was obtained by utilizing flow cytometry analysis to compare the expression of the pan Tcell surface marker, CD3, on peripheral lymphocytes (PLNs) isolated from NTx CBAlJ to
the expression of CD3 on PLNs from nonnal age matched nonthymectomized CBAlJs
(Figure 5.3). This analysis demonstrated that only 14 % of PLN lymphocytes from NTx
CBAlJ mice were positive for CD3 as compared to the 69% of PLN lymphocytes that were

positive for CD3 nonthymectomized CBAlJ mice (Figure 5.3).
Histological observations of reovirus IlL infected or saline inoculated control NTx
CBAlJ lungs were made on H&E stained paraffin embedded lung sections. By day 3 post

reovirus inoculation, a mixed inflammatory infiltrate composed primarily of macrophages in
addition to smaller subsets of polymorphonuclear (PMN) and mononuclear cells had
gathered diffusely in the alveolar spaces and the interstitium of the lung (Figure 5.4B). In
contrast, a cellular infiltrate was not observed in control lungs (Figure 5.4A). At day 7 post
reovirus inoculation the cellular infiltrate had become less diffuse, ·and more organized
around the bronchioles (Figure 5.4.C). The bronchoalveolar association of the cellular
infiltrate became more noticeable at two weeks after reovirus inoculation (Figure 5.4D).
Potential damage to the lung vasculature was also evident at two weeks after reovirus
inoculation by the presence of edema in the alveolar spaces associated with the cellular
infiltrate (Figure 5.4D, arrow). Higher magnification of the lesion two weeks after reovirus
inoculation further revealed the thickening of alveolar walls, indicating alterations to the
architecture of the lung (Figure 5.5A, large arrow). Additionally, at day 14 post reovirus
infection fibrous polyps of collagenous tissue had developed in the alveolar spaces affected
by the cellular infiltrate (Figure 5.5A, small arrow). As demonstrated in nonthymectomized
CBAlJ mice the fibroblastic polyps in NTx CBAlJ mice could be observed in terminal

bronchioles, alveolar ducts and alveoli. The continued development of these fibroblastic
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polyps resulted in the formation of mature BOOP lesions by 21 after reovirus inoculation
(Figure 5.5B).

These BOOP lesions were patchily distributed in the lung and were

associated with prominent clusters of intra-alveolar populations of foamy macrophages
(Figure 5.5B, arrow).
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Cell
Number

CD3 Expression
Figure 5.3. Flow cytometric analysis of splenic populations for the pa-T lymphocyte
marker CD3 from normal and neonatally thymectomized (NTx) CBAlJ mice.
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Figure 5.5. Histological characterization of BOOP in NTx CBAlJ mice. Day 14 after
reovirus IlL infection (A). Day 21 after reovirus infection (B).
Magnification, X 40
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appears to be dose dependent relationship since a ten-fold increase in the titer of the viral
inoculum results in 90% of the CBAfJ mice developing ARDS and 10% developing BOOP.
It is difficult to determine if those CBAfJ mice that develop ARDS following reovirus
inoculation could also develop BOOP since edema, RBC congestion, and hyaline membrane
formation precede BOOP lesion development by 2 to 3 days. It is during this interim that
the CBAfJ mice that develop ARDS die of ARDS-related causes, before the time at which
BOOP lesion formation is most likely to occur.

It is possible, however, that ARDS

represents a more acute form of the inflammatory reaction that results in the development of
BOOP lesions. In humans histopathological observations of acute inflammatory responses
in the lower respiratory tract suggest that ARDS is representative of a more severe form of
the same type of inflammatory reaction that precedes BOOP formation (Wright, et al.
1992). Generally, among those individuals that survive ARDS, most will also develop
BOOP (Kuhn, et al. 1989).
The participation of T-Iymphocytes in the development of the acute inflammatory
reaction in the lungs of CBAfJ mice following respiratory reovirus infection is suggested by
a marked reduction in the severity of the reovirus-induced pulmonary inflammatory
response in T -lymphocyte-deficient neonatally thymectomized (NTx) CBAfJ mice.
However, NTx CBAfJ mice still develop BOOP lesions following- reovirus infection, even
though the reovirus-induced cellular infiltrate is dominated by macrophages and
significantly less lymphocytic than observed in nonthymectomized CBAlJ mice following
respiratory reovirus infection. These observations suggest the possibility that two separate
components of the reovirus-induced inflammatory response can be identified in CBAlJ
mice. The first aspect of the pulmonary inflammatory response to reovirus in CBAfJ mice
could be a T-cell independent process that is primarily mediated by resident parenchymal
cells and results in the development of intraluminal fibrotic lesions. A second component of
the reovirus-induced pulmonary inflammatory response that is characterized by the
development of ARDS may be a T-lymphocyte mediated progression of the inflammatory
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reaction to an acute stage defined by the widespread vascular endothelial and alveolar
epithelial destruction.
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CHAPTER 6

Final Discussion
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Mechanisms that mediate the pathogenesis of inflammatory and fibrotic disorders of
the bronchoalveolar compartment of the lungs remain ill-defined even though these
disorders are becoming increasingly recognized as important secondary complications of
connective tissue disorders, bone and lung transplantation, toxic fume exposure, and viral
and bacterial infection (Epler 1992, Wright, et al. 1992, Wells and du Bois 1993, Myers and
Colby 1993, Kanda, et al. 1997). Numerous observations of inflammatory diseases of the
small airways by pathologists and morphologists have resulted in well-established
histopathological descriptions of these disorders (Kuhn, et al. 1989, Wright, et al. 1992,
Wells and du Bois 1993, Myers, et al. 1994). Such accounts of inflammation in the lung
have resulted in the suggestion that many small airway inflammatory and fibrotic disorders
belong to a continuum of lung disease, unified by a foundation of lymphocyte accumulation
in the alveolar and interstitial compartments of the lung (Wright, et al. 1992, Myers and
Colby 1993). However, the cellular and molecular events that orchestrate the regulation of
pulmonary inflammation and fibrosis have not been well-delineated.

The reovirus IIL-

induced model of respiratory inflammation strongly suggests that the genetic backgrounds
of diffl!rent strains of mice contribute to the biological mechanisms that control the
pulmonary inflammatory response to a single pathogenic agent. - In this model system
respiratory reovirus-IlL infection can be used in CBAlJ mice to generate the acute small
airway disorders BOOP and ARDS. In contrast, respiratory reovirus IlL infection of eD1, Balb/C, and C3H mice generates FB, a significantly less intense inflammatory reaction

that is not accompanied by fibrosis or severe parenchymal cell damage.
Several observations suggest that the variability in lung pathology among these
mouse strains following reovirus infection is more related to the regulatory events of the
inflammatory response to reovirus than to just simply the susceptibility of each strain to
reovirus-mediated lytic cell damage. These include: (i) the titer of the inoculum of reovirus
IlL used to infect CBAlJ mice (BOOP and ARDS) is ten-fold lower than that used to infect

99
CD-I, Balb/C, and C3H mice (FB); (ii) the clearance of infectious reovirus-IlL from the
lungs CBAlJ mice and CD-l mice occurs with similar kinetics; and (iii) reovirus-IlL
replication ceases in the lungs of CBAlJ mice and CD-l mice with similar kinetics.
Normally, following injury to the alveolar epithelium, the lung generates proteolytic
enzymes to reduce the presence of fibrin and other ECM proteins in the air spaces (Simon
and Paine 1995). In particular, the activity of the urokinase-type plasminogen activator has
been implicated as the major fibrinolytic factor in the lung (Idell S, et al. 1988, 1989;
Bertozzi, et. al. 1990).

In both animal models and in humans decreased activity of

urokinase has been associated with the development of ARDS (Idell et al. 1989; Bertozzi et
al. 1990).

Therefore, it is possible that regulatory differences in ECM proteolytic

mechanisms between CBAlJ mice and other mouse strains may also contribute to the acute
pulmonary inflammatory response to reovirus in CBAlJ mice that is manifested by BOOP
and ARDS.

In the experimental model of interstitial lung inflammation and fibrosis

induced by the toxic chematheraputic, bleomycin the lungs of C57BU6N mice (H-2b ) are
exquisitely sensitive to bleomycin and respond to both i.t. and i.v. administration of
bleomycin with intense lung inflammation and interstitial fibrosis (Baecher-Allan and Barth
1993). However, BALB/c mice (H-2 d) are generally considered to be resistant to the
inflammatory and fibrotic events occurring after bleomycin treatment (Janick-Buckner, et al.
1989). The initial nuclear damage mediated by bleomycin to the bronchiolar and alveolar
epithelium was equivalent in C57BU6N and BALB/c mice; however, C57BU6N mice
demonstrated lower levels of hydrolase (enzyme that breaks down bleomycin) and increased
levels of poly ADP-ribose polymerase (mediates cell damage by depleting NAD+) in
comparison to BALB/c (Rossi, et al. 1987). These results are evidence of the strong role
cellular enzymes may have in determining the susceptibility to pulmonary fibrosis.
An association between expression of the murine major histocompatability complex
(MHC) haplotype H-2b, which is expressed by C57BU6N mice, and acute lung
inflammation and fibrosis has also been demonstrated in the bleomycin model (Janick-
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Buckner, et ale 1989). Whereas, mouse strains expressing H-2a, H-2d, and H-2k haplotypes
are generally low responders to bleomycin. When the H-2 haplotype of a low responder
strain like Balb/C is inserted to a high responder background like C57BU6N, there is
considerable decrease in pulmonary fibrosis following i.t. bleomycin treatment (Rossi, et ale
1987). Likewise the movement of a high responder H-2 haplotype to a low responder
background can result in an increase in intensity of the fibrotic response to bleomycin
(Rossi, et al. 1987).

An analogous link between MHC background and an acute

inflammatory response to respiratory reovirus infection was not demonstrated between
CBAlJ and the other mouse strains screened with reovirus. The haplotype H-2k is shared

by CBAlJ and C3H mice, yet in response to respiratory reovirus infection CBAlJ mice
develop BOOP or ARDS, but the reovirus induced response in C3H mice is characterized
by a relatively mild lymphocytic infiltration into the interstitial and alveolar spaces of the
lung.
In both clinical cases and in animal models, bleomycin induced lung injury is
accompanied by an inflammatory infiltrate (Janick-Buckner, et ale 1989). The inflammatory
infiltrate is typically characterized by PMNs and lymphocytes (Janick-Buckner, et ale
1989).

The infiltration of PMNs only occurs in the early stages of the response to

bleomycin, but the lymphocytes persist throughout the fibrosis- (Janick-Buckner, et ale
1989). Most of the lymphocytes are T cells and only 10% of the lymphocytes are B cells
(Janick-Buckner, et al. 1989).

When the bleomycin fibrosis model is moved from

C57BU6 mice to outbred nude athymic C57BU6N mice, which lack a nonnal T-

lymphocyte component of the immune response, the reSUlting pulmonary fibrosis is similar
between the normal and nude animals, which suggests that T-lymphocyte independent
mechanisms may be involved in the pulmonary fibrotic process in response to bleomycin
(Szapiel, et ale 1979). Also, in vivo antibody depletion of CD4+ or CD8+ popUlations does
not appear to alter the course of pulmonary fibrosis in C57BU6J mice; however, the role of
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T -lymphocytes in the tissue remodeling that occurs late in the fibrotic process has not been
investigated (Janick-Buckner, et al. 1989).
The prominence of infiltrating lymphocyte populations in the CD-l model of FB
and of the CBAlJ model of BOOPfARDS (Bellum, et a1. 1996, Bellum, et al. 1997) reflect
the association of lymphocytic infiltrates with human FB, BOOP, and ARDS (Yousem, et
al. 1985, Wright, et al. 1992, Kuhn, et al. 1989). T-Iymphocytes have also been identified

as primary mediators of inflammation and fibrosis in models of interstitial pulmonary
fibrosis (Suzuki, et al. 1996, Sharma, et al. 1996, Zhu, et al. 1996). In the lungs of Tlymphocyte deficient NTx CBAlJ mice the reovirus-induced cellular infiltrate is not
characterized by a prominent lymphocytic component, but is instead largely composed of
macrophages and PMNs.

Despite the decreased presence of T-Iymphocytes in the

reovirus-induce inflammatory infiltrate Ntx CBAlJ mice continue to develop characteristic
BOOP lesions, but do not develop the widespread vascular damage associated with ARDS.
These observations suggest that the initiating event for BOOP and ARDS may be related to
the reaction of the lung parenchyma to reovirus infection; however, the pathogenesis of
ARDS may involve a T-lymphocyte mediated mechanism.
Clearly, lung inflammation and fibrosis involves a complex network of interactions
between a large number of cell types. Infection of resident pulmonary populations of cells
by reovirus may initiate the production of a unique pattern of pro-inflammatory cytokines or
non-peptide mediators which contribute to the characteristic pathologies observed in CBAlJ
mice versus mouse strains that do not develop an acute pulmonary inflammatory response
to reovirus IlL. Investigations utilizing reovirus IlL infection of mice will provide a model
to systematically investigate the cellular and molecular mechanisms that lead to the
development as well as the resolution of acute inflammatory diseases like BOOP and
ARDS. Such studies are of significance not only for understanding the pathophysiology of
FB, BOOP and ARDS, but are of broader significance since it is likely that a large
proportion of inflammatory disorders of the distal regions of the lung exist undetected in
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the population until they become symptomatic or life-threatening.

Consequently, an

improved understanding of the development and resolution of reovirus IlL-induced
inflammatory lung lesions may give great insight into the natural course of common lung
diseases.
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